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Abstract
Background: Recruitment and retention of patients and healthcare providers in randomised controlled trials (RCTs) is
important in order to determine the effectiveness of interventions. However, failure to achieve recruitment targets is
common and reasons why a particular recruitment strategy works for one study and not another remain unclear. We
sought to describe a strategy used in a multicentre RCT in primary care, to report researchers' and participants'
experiences of its implementation and to inform future strategies to maximise recruitment and retention.
Methods: In total 48 general practices and 903 patients were recruited from three different areas of Ireland to a RCT
of an intervention designed to optimise secondary prevention of coronary heart disease. The recruitment process
involved telephoning practices, posting information, visiting practices, identifying potential participants, posting invitations
and obtaining consent. Retention involved patients attending reviews and responding to questionnaires and practices
facilitating data collection.
Results: We achieved high retention rates for practices (100%) and for patients (85%) over an 18-month intervention
period. Pilot work, knowledge of the setting, awareness of change in staff and organisation amongst participant sites, rapid
responses to queries and acknowledgement of practitioners' contributions were identified as being important. Minor
variations in protocol and research support helped to meet varied, complex and changing individual needs of
practitioners and patients and encouraged retention in the trial. A collaborative relationship between researcher and
practice staff which required time to develop was perceived as vital for both recruitment and retention.
Conclusion: Recruiting and retaining the numbers of practices and patients estimated as required to provide findings
with adequate power contributes to increased confidence in the validity and generalisability of RCT results. A continuous
dynamic process of monitoring progress within trials and tailoring strategies to particular circumstances, whilst not
compromising trial protocols, should allow maximal recruitment and retention.
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Background
Introduction
Two of the most important challenges in clinical research
are those of recruitment and retention [1-8]. Difficulty
with recruitment can cause lengthy time delays to a
research project. If not foreseen, this can cause problems
with budgetary constraints, which may consequently lead
to shortening the duration of the study intervention [9]. A
recent report indicates that one third of trials are forced to
seek additional funds due to recruitment delays [10].
As high proportions of patient contacts occur in primary
care, e.g. 90% within the NHS [11], general practice offers
the potential of access to large numbers of participants for
research studies, but recruitment in this setting involves a
particular succession of challenges. It is a two-step proc-
ess, requiring firstly the consent of staff in an increasingly
busy work environment where space and time are fre-
quently limited, and then the consent and commitment
of sufficient numbers of eligible patients. Previous reports
suggest reasons why primary care practitioners and
patients become involved in research. Practitioners' rea-
sons range from deriving satisfaction in helping to estab-
lish correct treatment decisions to an opportunity for
practice staff to participate in research: they may be
attracted to participate in a study when they consider the
research relevant and necessary, and the research study
team experienced and supportive [12-15]. Patients' rea-
sons include potential advantages in care received (for
example longer consultation time and regular physical
measurements), the attitude of researchers, the quality of
information supplied and also altruism, hoping that their
participation will benefit others [16,17].
It cannot, however, be assumed that all practitioners and
patients will be interested in taking part in research. Some
practitioners may have difficulty envisaging how their exist-
ing working practice could accommodate research activities
[13] being concerned about the potential disruption to staff
and patients, increasing demands on time [6,8,14,18], lack
of support [19], the burden of rigorous data collection [20],
adverse impact on the doctor-patient relationship, and
reluctance to commit patients to incurring expenses in
travel and time [19]. Patients' concerns include reconciling
compliance with research protocols (e.g. follow up
appointments) and demands of their lives, especially with
caring responsibilities and work commitments, environ-
mental factors (such as lack of transportation), unintelligi-
ble questionnaires and perceptions of unpleasant
interventions: they may simply lack interest in research,
have inadequate understanding of the study or mistrust the
investigators. Patients who do participate in trials experi-
ence waning motivation over time [1,16,21,22].
Even when practices are committed to the study it is no
guarantee that the recruitment and retention of study
patients whose consensual participation is key to the suc-
cess of the study will be straightforward [23]. Factors
influencing recruitment also influence retention. Previous
studies report little detail of how knowledge of barriers
and facilitators to recruitment can be successfully trans-
lated into future strategies [8]. This paper aims to report
the difficulties and successes experienced in attempting to
apply previous knowledge to the recruitment and reten-
tion of participants in the 'SPHERE' study, a RCT of an
intervention for secondary prevention in coronary heart
disease [24] and to identify practical guidance for improv-
ing recruitment and retention of practitioners and
patients to benefit future research studies [25].
Setting and Sample
Coronary heart disease (CHD) remains one of the com-
monest causes of premature death worldwide and evidence
suggests secondary prevention remains sub-optimal.
The SPHERE study is a RCT of a tailored intervention to
improve secondary prevention of CHD in general practice
[24]. It is set in two study regions in the Republic of Ireland
(RoI): West and East, and one in Northern Ireland (NI).
The system of general practice organisation is different in
RoI and NI (Figure 1) necessitating our recruitment strategy
to be equally applicable to both healthcare systems. The
study follows the MRC framework for developing and eval-
uating complex interventions [26]: this descriptive report
highlights how preliminary findings inform a definitive
trial and how details of the context of a trial are relevant to
its evaluation.
During a pilot study of the intervention in four practices,
two in RoI and two in NI, qualitative research [27] pro-
vided valuable insights into issues surrounding recruit-
ment and retention. Such issues included the value of
phone call contact for improving uptake, the shortage of
space in premises, the need for strategies to deal with wan-
ing enthusiasm, clear protocol structures, patient non-
attendance due to duplication in chronic disease manage-
ment clinics and minimizing research workload for prac-
titioners. These issues informed the design of our
intervention and our approach to recruiting and retaining
practices and patients. Following this pilot, the main RCT
took place complemented by a parallel qualitative evalu-
ation of the intervention with a purposive sample of
patients (n = 67), practitioners (n = 26) and research
nurses (n = 4) (Corrigan M, D'Eath M, Cupples ME, Wil-
son J, Murphy AW. Participants' experiences of a complex
intervention for the secondary prevention of heart disease in
general practices in Ireland – the Sphere study. Submitted). A
small element of this qualitative arm explored perceptions
of the recruitment process, data which helped to inform
this paper. Research nurses also recorded their observa-
tions and participants' comments about the process dur-
ing the trial.
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Methods
Practice Recruitment
Practice recruitment began with the sourcing of a list of all
potentially eligible practices from the local relevant health
authority. Practices were eligible to take part if they had a
practice nurse involved in general patient care, did not
contribute to the pilot phase of the study, were not partic-
ipating in 'Heartwatch' (a limited RoI government initia-
tive for the secondary prevention of CHD) and had a
minimum General Medical Services (GMS) list size of 700
(RoI) or National Health Service (NHS) list size of 1800
(NI). In NI the NHS offers free primary health care serv-
ices to all and people register for care with a specific gen-
eral practice; in the RoI free services are only provided to
Characteristics of Healthcare Systems in Northern Ireland and Republic of IrelandFigure 1
Characteristics of Healthcare Systems in Northern Ireland and Republic of Ireland.
Northern Ireland (NI) Republic of Ireland (RoI)
National Health Service (NHS) funds 90% of health
care through government taxation.
Health care funded through a mixture of general
taxation, social and private insurance and personal
‘out of pocket’ expenses.
Everyone has free access to hospital care and a family
practitioner.
Hospital care is free of charge for all.
Charges for each prescription item are subsidised by
the government.
Only those on the lowest income (approx 27%) have
free access to a Family
Many people are exempted from payment for
prescriptions for medical or social reasons.
Practitioner and to free prescriptions: these are
classified as General Medical Services (GMS)
patients.
Almost 90% of all prescriptions are dispensed free of
charge.
Non-GMS patients must pay for visits to the family
practitioner and practice nurse approx ¼35-50 per visit
(£24-34) and for all prescriptions up to a value of ¼75
(£50) per month.
High Starfield score.* Intermediate Starfield score.*
*The Starfield score reflects the strength of primary care in a country. (Starfield B. Primary care:
Balancing health needs, services and technology. Oxford University Press, Oxford 1998).
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patients who are deemed to be 'GMS eligible', using crite-
ria such as age and income [28]. Family practitioners in
the RoI have formal lists of such patients but also treat
others whose care is funded from other sources and do
not have formal lists of these, hence the GMS list was used
as an indicator of minimum practice size. Determining
practice eligibility in the RoI involved the research nurses
telephoning 205 practices from their lists to ascertain this
information. In NI information about practices' NHS list
sizes was available by contacting a central administrative
office. Subsequently during initial invitation phonecalls,
five practices on the list were found to be ineligible due to
not employing a practice nurse but utilizing Health Trust
treatment room nurses.
Practices identified within each region as being eligible for
inclusion were assigned a number and a researcher inde-
pendent of the SPHERE study listed them in random
order using computer generated random numbers. The
lists were also stratified in each region by the number of
whole-time equivalent GP partners per practice.
Initial Contact with Practices
Using the randomly ordered lists, potentially eligible
practices were telephoned in sequence by the research
nurses to achieve the target number needed for the study.
The nurses avoided making these calls at especially busy
times such as Monday mornings and Friday afternoons
and asked reception staff for appropriate times to speak to
a GP or practice manager, not wanting to use time slots
reserved for patients. The purpose of the initial phone call
was to confirm practice eligibility for participation in the
study and ascertain their interest in receiving further infor-
mation. Practitioners were given a brief explanation of the
study and asked if they would like to receive the study
information sheet. Mention was made of a minor finan-
cial payment (€1000/£700) in recognition of the addi-
tional costs in time and resources practices might incur,
including making phone calls to ask patients to attend
appointments, using a room for SPHERE consultations
and collecting research data. Practitioners who expressed
interest were posted a letter and the study information
sheet, presented on one A4 sheet as opposed to multiple
pages, for ease of reading. It included details of the pro-
jected practice workload and the extent of patient involve-
ment whether randomly selected as an intervention
practice or a control practice. Practices were contacted
after ten days to ascertain decisions regarding participa-
tion. These decisions were recorded onto a database along
with reasons for disinterest, if given.
The research nurse visited practices who expressed an
interest in taking part in the study to explain the project
more fully and provide the opportunity for practitioners
to ask questions face to face. Visits were arranged at the
practice's convenience, usually being held over lunchtime
and an invitation was extended to all practice staff in rec-
ognition that the study would involve their cooperation
and also to promote 'practice' (rather than individual
staff) ownership of the study. Practice data (e.g. staffing
information, computerisation and special interests) were
collected onto a Practice Recruitment Form and the study
eligibility criteria were confirmed. Specific needs or
requirements that the practice had in relation to the study
were also recorded for follow-up by the research nurse. A
key member of staff was identified for further communi-
cation in order to clarify communication channels and
avoid contacting other staff unnecessarily. Practices who
wished to take part completed a form signed by each prac-
titioner to indicate their agreement to participate. They
then received a letter welcoming them to the study and
were assigned a practice study number.
A small honorarium was given to reimburse practices
once they had completed recruitment. This payment did
not represent significant financial gain for practices but
was intended as an acknowledgment or 'thank you' for
their work. It was paid to the practice and not to individ-
ual practitioners who were central to carrying out SPHERE
study consultations.
Patient Recruitment
Patients eligible for inclusion in the study were those with
a documented CHD diagnosis defined as: previous acute
myocardial infarction confirmed by ECG, cardiac
enzymes and/or serum troponin levels, angina confirmed
by exercise stress test, angiogram or thallium scan, coro-
nary artery bypass graft (CABG) or percutaneous translu-
minal coronary angioplasty (PTCA), without terminal
illness or housebound. Potentially eligible patients were
identified in NI by accessing the computer based CHD
registers that already existed and were used in the NHS GP
contract [29]. In the RoI the research nurses facilitated the
recruited practices to generate lists of CHD patients. This
involved searching both paper and computer records
(involving five different computer software packages) for
hospital letters and prescriptions, accessing other existing
disease registers e.g. of diabetic patients, and consulting
with practice staff about patients they could remember
who had a cardiac event or procedure. Each practice was
asked to recruit a minimum of twenty patients.
Eligible patients randomly selected from each practice's
CHD register, using computer generated numbers from a
remote location, were contacted by post. The mailing
included a letter, signed by a named member of the prac-
tice staff, inviting participation in the study and the
SPHERE study information sheet, with telephone num-
bers to contact the project manager or research nurse if
wished. A questionnaire was also included containing a
BMC Medical Research Methodology 2009, 9:40 http://www.biomedcentral.com/1471-2288/9/40
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helpline number in case difficulties were encountered
with completion, and a reply slip and stamped practice
addressed envelope to indicate interest in participation
(with a request for their telephone number if interested).
For confidentiality reasons the SPHERE questionnaire
contained the patient's study number (not name or
address) to enable identification of returned question-
naires which were stored securely at the practice until col-
lected by the research nurse. In order to keep an account
of the patient recruitment process and questionnaire com-
pletion rate, details of the mailing were recorded on the
Patient Progress Form; this form included all replies
received and those who did not respond. Non-responders
were followed up 10 days after mailing by a reminder let-
ter and/or a phone call. Patients who responded positively
were invited to attend an initial baseline consultation
with their practitioner.
Obtaining Consent and Collecting Baseline Data
The research nurse visited the practitioners prior to the
first patient consultation to review the study protocol and
discuss key study issues, including the process of obtain-
ing patient informed consent, the purpose and format of
quality assurance visits, and most importantly communi-
cating the vital role the practitioner would play through-
out the study in relation to interacting with patients and
implementing the intervention. Practitioners received
training on obtaining standardised clinical measurements
including blood pressure, cholesterol, body mass index
and waist hip ratios. A minimum of two baseline quality
assurance visits with individual practitioners were under-
taken by the research nurses during the initial and later
patient consultations. Once the baseline measurements
had been obtained for all twenty patients the practices
were randomly divided into either control (usual care) or
intervention allocations.
Based on findings of our pilot work, training on delivering
the intervention (recalling participating patients and
delivering a consultation at 4 monthly intervals for the
duration of the study) was provided for intervention prac-
tices during two 90 minute in-house training sessions. The
time and detail of this training was tailored to individual
practice and practitioner needs.
Retention strategy
The practicalities of recording and storing research data in
the practices were addressed by providing a data collec-
tion form one page in length and a laminated colour
coded reference list of CHD medications to aid practition-
ers' recording of patient's drugs within specified catego-
ries. A red storage box was offered to hold all study
materials, with carry handles for easy transport and a 'han-
difile' to store paperwork. Other documentation provided
included a SPHERE practice manual; this colourful con-
venient document detailed the study protocol and
included detachable A4 laminated cards which set out pic-
torially each step of the consultations. The red storage box
was designed following feedback from the pilot study
where practice nurses identified that they did not always
have a designated room for their clinics but were assigned
any available room on a daily or weekly basis. All these
measures helped to smooth the course of the study for
busy practices, thus increasing the likelihood of retaining
their participation.
Intervention practitioners received further quality assur-
ance visits from the research nurses who observed and
assessed randomly selected patient consultations in order
to monitor and enhance the methodological quality
measures of the health behaviour intervention, recording
any deviations from the agreed standard [30]. The quality
assurance visit form was also used to provide feedback to
practitioners on the prescribed content within their con-
sultations and comments were invited. Arrangements
were made for follow-up contact from the research nurses
who telephoned practices two weeks before patient visits
were due both as a reminder and as an opportunity to dis-
cuss any problems or queries. The research nurses for-
warded the QA forms to the study project manager who
coordinated and supported their efforts and shared inno-
vations experienced enhancing the smooth running of the
study. The project manager produced a reader-friendly
newsletter for distribution to intervention practices. This
was designed to help reinforce the practices' position as an
integral part of the entire study, provide information
about the study progress and highlight relevant current
issues in CHD.
While intervention practices by necessity received more
support for retention than control practices, this was not
viewed as a source of bias since practice support from the
research team was an explicit component of the SPHERE
intervention.
Results
Practice participation rates and reasons
A total of 845 practices were identified as potentially eligi-
ble, 711 in the RoI and 134 in NI. To recruit the target
number of 48 practices (16 in each of the three regions),
the research nurses invited, in sequence of random order,
165 of those which fulfilled the inclusion criteria: 109
declined, 56 who declared interest were visited and agreed
to take part, but eight withdrew shortly afterwards for var-
ying reasons (Figure 2), giving a participation rate of
33.9% (48/165). Recruitment of the target number of 48
practices took 12 months. Characteristics of participating
practices are shown in Table 1. To recruit the 16 practices
in NI a log record showed that a total of 288 phone calls
were made, including unsuccessful attempts to speak to
BMC Medical Research Methodology 2009, 9:40 http://www.biomedcentral.com/1471-2288/9/40
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appropriate personnel (Figure 3). The reasons for practice
non participation are shown in Figure 2.
Patient participation rates
We posted a total of 1795 invitation letters to patients and
received 1492 (83%) responses (Table 2); 998 (55.6%)
expressed an interest in participating and 903 (50.3%)
attended baseline consultations and signed consent
forms. Characteristics of non participating patients are
shown in Table 3. The remaining 95 patients cancelled/
did not attend appointments or were deemed ineligible;
none of those who attended a baseline consultation
declined study participation.
Retention issues
Throughout the study period practices experienced a vari-
ety of changes including key staff members changing jobs
or retiring, seasonal increases in work loads such as "flu
jab season" and the execution of necessary building work
to premises. Patient attrition was caused by study visits to
the practice becoming impracticable due to changes in cir-
cumstances or interest while others were unable to attend
due to deterioration in their medical condition(s).
The crucial retention of both practices and patients was
supported by the research nurses who attempted to mini-
mise problems by sustaining practice contact both by tel-
ephone and practice visits to ensure ongoing needs
assessments. They provided tailored support as appropri-
ate, such as facilitating the practice through heavy work
commitments, retraining new staff members, undertaking
any extra administration duties generated by the study
and helping contact and encourage patients who
defaulted on appointments. Problems and solutions
encountered were recorded electronically in a database in
conjunction with quality assurance visits and monitored
by the project manager. This ensured knowledge of treat-
ment fidelity and facilitated practice support. Feedback
was not only provided to practices through the Quality
Assurance visits but also by the 'Practice Care Plan', which
was designed to facilitate practitioners implementing the
intervention and was updated as the study progressed. It
included dates of QA visits and patient follow up consul-
tations and recorded specific requests for support which
the research nurse followed up. A copy was kept both at
the practice and the research centre. Regular personal
communication with the practices facilitated retention
through the prompt resolution of their difficulties.
In qualitative interviews practitioners stated that the sup-
port received in dealing with queries in the early setting up
stages and first patient consultations was very important.
Regular phone calls, particularly the reminder calls were
felt to be beneficial in helping practices to adhere to the
study protocol and timeline. Knowing that they had good
telephone access to the research nurses by direct contact
numbers and having queries dealt with very quickly pro-
vided the necessary support they required. Practitioners
valued the nurses being approachable, encouraging, help-
ful, friendly, reassuring and supportive. At study comple-
tion after at least 18 months, none of the 48 practices and
15% (135/903) of the patients who participated had with-
drawn.
Discussion
This paper reviews the experiences of recruitment and
retention within a multicentre RCT delivered in primary
care. It highlights the advantages of introductory tele-
phone calls to practices, followed by postal information
and face to face meetings in achieving high retention
within a trial. We invested considerable effort in establish-
ing and maintaining recruitment and retention, using
resources which may not always be available to others,
but the importance of identifying resources for these
aspects of a research project should not be underesti-
mated. Below we try to distil the key components of a suc-
cessful strategy. The lessons to be learned may differ,
depending on the healthcare setting in which future
research is to be conducted.
Initiating contact
The active recruitment measures used allowed personal
contact between researchers and practitioners and
avoided mailing unsolicited information, both of which
Table 1: Characteristics of practices involved in SPHERE
PRACTICES
Single Handed Two Partner Three Partner Four Partner > Four Partners
North 1 7 6 0 2
RoI East 8 3 1 4 0
RoI West 7 4 1 4 0
Totals 16 14 8 8 2
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Flowchart of Practices Approached and Recruited into SPHEREigure 2
Flowchart of Practices Approached and Recruited into SPHERE.
Practices identified in the chosen regions in Republic of Ireland and
Northern Ireland
n = 845
Excluded
n = 579
Confirmed eligible
n = 266
Number of practices invited to
participate
n = 165
Practices unwilling to
participate n=109
Workload/Current time
commitments (n=50)
Staff Issues (n=19)
Not interested in
SPHERE/Research in
general (n=9)
Other reason/ No reason
given (n=31)
Practices willing to
Participate n = 56
Practices
unable to
proceed
n = 8
Total
practices
recruited
n = 48
Insufficient
number of eligible
patients (n=5)
Staff Issues (n=2)
Building
renovations (n=1)
Practices requiring contact re eligibility
n = 210
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are factors which encourage research participation [13].
The researcher's ability to engage the practitioner is central
to positively facilitating decisions to participate and the
vital ensuing relationship with the general practice team,
especially when practices have not formerly participated
in research. Previously reported practitioner recruitment
rates [12] were higher (up to 91%) when personal meet-
ings took place as opposed to recruitment by a telephone
call alone (75%). However, 78% of practitioners recruited
in that study were either friends or acquaintances of the
study team, rather than randomly selected practitioners.
Asking healthcare providers to recruit patients following
receipt of uninvited study information has been identified
as a relatively unsuccessful method of recruitment [31].
Researchers who intend to recruit practices by posting an
initial letter introducing the study are advised to ensure
this is followed up with a timely phone call [13]. One RCT
which asked physicians to deliver a smoking cessation
intervention reported a participation rate of 9.8% when
information was posted as opposed to 59% using face-to-
face recruitment efforts [32].
Providing information
The importance of an informed approach by the research
team to recruitment of practices and patients cannot be
underestimated [33]. Involving all practice staff in the vis-
its allowed the research nurses to ensure that practices
could be made fully aware of the not inconsiderable work-
load entailed in study participation for individual practice
members and the commitment expected from patients.
While this appeared to have a detrimental effect on our
practice recruitment rate (33.9%) it proved a facilitator in
the retention of both participating practices (100%) and
patients (85%). Studies with high rates of patient recruit-
ment cannot necessarily be perceived as superior to those
Belfast Region Recruitment Phone CallsFigure 3
Belfast Region Recruitment Phone Calls.
114 108
66
288
0
50
100
150
200
250
300
Logged
Telephone
Calls
1General Practices
Contacted =61
Practice Recruitment (Belfast)
Call duration less than 2
mins
Call duration more than 2
mins
Unsuccesful call
engaged/no reply
Total logged calls
Table 2: Number of patients approached by practices
PATIENTS
Invited Declined No Response Agreed Rate of recruitment
North 760 252 158 350 46.0%
RoI East 562 131 97 334 59.4%
RoI West 473 111 48 314 66.4%
Totals 1795 494 303 998 55.6%
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with a lower rate [8] when other measures such as partic-
ipant retention and treatment compliance also need to be
taken into consideration. Practitioners who consent to
participate in studies on the basis of inadequate informa-
tion are more likely to withdraw early once the actual
implications of participation become clear [15].
Recognising time and place
The time spent by the research nurses at the outset visiting
practitioners and providing training was thought to con-
tribute to the fact that none of the patients who attended
initial appointments at the practices declined participa-
tion. This, and the low rate of patient attrition, may be
associated also with the initial posting of study informa-
tion to patients, allowing them time to consider potential
participation and discuss this with family or friends.
Based on the pilot work findings, practices were encour-
aged to combine patient visits where possible if overlap
with other chronic disease clinic attendance was identi-
fied, in order to avoid duplication of service provision and
minimise patient expenses in travel and time.
It could be argued that patients with a past medical history
of heart disease are sufficiently motivated to access medi-
cal interventions but previous research has reported that
service uptake by these patients is less than optimal
[34,35]. Also, using the practice address as a contact point
for information and return of responses rather than an
unfamiliar address was deemed to be more 'user friendly'
for patients and kept the practice informed regarding
replies received. Our findings suggested that this yielded a
sample in which there was an absence of bias in response
in respect of age and gender. We achieved a patient partic-
ipation rate of 56%, considerably higher than the 38%
response rate of patients with angina invited to participate
in a recently reported trial [36].
Involving practices
Our practice recruitment rate appeared lower than that
(69%) in a previous study [3] which employed a similar
process but recruited individual physicians, rather than
practices. We required agreement by all partners within
each practice, necessitating exclusion of some individuals
who were willing to take part. Also, we required the prac-
titioners to recruit the study patients and deliver the inter-
vention whilst some studies supply their own clinical
researchers to conduct patient enrolment and the study
process does not increase the normal practice workload
[37]. Our recruitment rate was similar to that reported
previously in a cluster RCT exploring different methods of
promoting secondary prevention of CHD (21 of 64 eligi-
ble practices; 32%) [38] but details of the support offered
within that study were scant and it did not involve patient
recruitment at the outset. The generalisability of study
results may be improved if more practices with low levels
of interest in research activity participate [9]. Direct finan-
cial recognition of individual practitioners' work associ-
ated with the research, rather than rewarding practices'
participation in the study, may act as a more effective
incentive. However, non-monetary incentives such as
addressing practitioners' concerns and providing support
through personal contact by the research staff may be
equally encouraging [39].
Challenges for the Future
Randomised trials continue to be an ever-increasing chal-
lenge in primary care due to difficulties in recruiting and
retaining practices and patients. If the benefits of practice-
based research are to be realised it is imperative that the
challenges of adding research to a service that reports an
expanding everyday workload [40] are minimised. Our
experiences in the SPHERE study should inform future
primary care-based research studies and help improve
practice and patient participation and retention. We sug-
gest consideration of the following key issues:
1 Designing a study with clinical relevance to primary
care, in accordance with current service provision.
2 Carrying out a feasibility study to identify potential
problems and create awareness of healthcare organisation
in proposed research settings including pre-trial qualita-
tive data to obtain opinions from patients, practitioners
and ancillary staff in the context in which the trial is to be
delivered.
3 Having the research team efforts coordinated by a desig-
nated Project Manager.
Table 3: Patient non participant data
Variable Participants
(n = 903)
Non Participants
(n = 772)
P Difference [95% CI]
Male 69.9%
(n = 631/903)
62.5%
(n = 475/760)
0.001 7.4 [2.8, 11.9]
GMS (RoI only) 77.8%
(n = 452/581)
81.7%
(n = 313/383)
0.141 -3.9 [-8.9, 1.3]
Age [Mean (SD)] 67.480 (9.6)
(total n = 903)
67.477 (10.7)
(total n = 730)
0.995 0.003 [-0.998, 1.005]
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4 Providing information regarding projected workloads at
the outset, especially if practitioners are required to recruit
and consult with the study participants.
5 Assessing practice needs initially at the recruitment stage
and ongoing throughout the study via a practice care plan.
6 Providing effective, sustained communication between
the research team and practice staff and patients by phone
calls prior to patient reviews and by extra visits when prac-
tices experience problems such as key staff members leav-
ing.
7 Providing ongoing written information e.g. in the form
of a study newsletter reporting on study progress, discuss-
ing issues which arise, and acknowledging the efforts of
practice staff.
8 Assisting practices with administration generated by the
study including helping contact defaulting patients and
posting out appointments.
9 Recording study data by research nurse rather than prac-
tice staff where possible, avoiding potential for observa-
tion bias.
10 Working collaboratively and supporting practice staff,
with speedy resolution of practice and patient queries.
11 Facilitating practitioners' and patients' study participa-
tion by ensuring all documentation provided is clear and
user-friendly.
12 Financial acknowledgement of practice staff directly
involved in the study.
Conclusion
The potential benefits of primary care research to clinical
outcomes are enormous. Facilitating the participation of a
wide range of practices and patients in pragmatic research
will allow increased confidence in the representativeness
and generalisability of findings, with consequent positive
impacts on patient care. The search for optimal methods
of maximising practitioner and patient recruitment
should continue.
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